Copyright Reports & Markets. All rights reserved.

Global Sirolimus Coated Stent Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Sirolimus Coated Stent Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Cobalt Chromium Alloy Material
    • 1.3.3 Stainless Steel Material
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Sirolimus Coated Stent Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Sirolimus Coated Stent Market Size & Forecast
    • 1.5.1 Global Sirolimus Coated Stent Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Sirolimus Coated Stent Sales Quantity (2020-2031)
    • 1.5.3 Global Sirolimus Coated Stent Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 QualiMe
    • 2.1.1 QualiMe Details
    • 2.1.2 QualiMe Major Business
    • 2.1.3 QualiMe Sirolimus Coated Stent Product and Services
    • 2.1.4 QualiMe Sirolimus Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 QualiMe Recent Developments/Updates
  • 2.2 Cardionovum
    • 2.2.1 Cardionovum Details
    • 2.2.2 Cardionovum Major Business
    • 2.2.3 Cardionovum Sirolimus Coated Stent Product and Services
    • 2.2.4 Cardionovum Sirolimus Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Cardionovum Recent Developments/Updates
  • 2.3 MicroPort
    • 2.3.1 MicroPort Details
    • 2.3.2 MicroPort Major Business
    • 2.3.3 MicroPort Sirolimus Coated Stent Product and Services
    • 2.3.4 MicroPort Sirolimus Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 MicroPort Recent Developments/Updates
  • 2.4 B. Braun
    • 2.4.1 B. Braun Details
    • 2.4.2 B. Braun Major Business
    • 2.4.3 B. Braun Sirolimus Coated Stent Product and Services
    • 2.4.4 B. Braun Sirolimus Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 B. Braun Recent Developments/Updates
  • 2.5 P+F Products + Features GmbH
    • 2.5.1 P+F Products + Features GmbH Details
    • 2.5.2 P+F Products + Features GmbH Major Business
    • 2.5.3 P+F Products + Features GmbH Sirolimus Coated Stent Product and Services
    • 2.5.4 P+F Products + Features GmbH Sirolimus Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 P+F Products + Features GmbH Recent Developments/Updates
  • 2.6 Terumo
    • 2.6.1 Terumo Details
    • 2.6.2 Terumo Major Business
    • 2.6.3 Terumo Sirolimus Coated Stent Product and Services
    • 2.6.4 Terumo Sirolimus Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Terumo Recent Developments/Updates
  • 2.7 Biotronik
    • 2.7.1 Biotronik Details
    • 2.7.2 Biotronik Major Business
    • 2.7.3 Biotronik Sirolimus Coated Stent Product and Services
    • 2.7.4 Biotronik Sirolimus Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Biotronik Recent Developments/Updates
  • 2.8 USM Healthcare
    • 2.8.1 USM Healthcare Details
    • 2.8.2 USM Healthcare Major Business
    • 2.8.3 USM Healthcare Sirolimus Coated Stent Product and Services
    • 2.8.4 USM Healthcare Sirolimus Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 USM Healthcare Recent Developments/Updates
  • 2.9 Concept Medical Inc
    • 2.9.1 Concept Medical Inc Details
    • 2.9.2 Concept Medical Inc Major Business
    • 2.9.3 Concept Medical Inc Sirolimus Coated Stent Product and Services
    • 2.9.4 Concept Medical Inc Sirolimus Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Concept Medical Inc Recent Developments/Updates
  • 2.10 MicroPort Scientific Corporation
    • 2.10.1 MicroPort Scientific Corporation Details
    • 2.10.2 MicroPort Scientific Corporation Major Business
    • 2.10.3 MicroPort Scientific Corporation Sirolimus Coated Stent Product and Services
    • 2.10.4 MicroPort Scientific Corporation Sirolimus Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 MicroPort Scientific Corporation Recent Developments/Updates
  • 2.11 Lepu Medical Technology
    • 2.11.1 Lepu Medical Technology Details
    • 2.11.2 Lepu Medical Technology Major Business
    • 2.11.3 Lepu Medical Technology Sirolimus Coated Stent Product and Services
    • 2.11.4 Lepu Medical Technology Sirolimus Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Lepu Medical Technology Recent Developments/Updates
  • 2.12 JW Medical Systems
    • 2.12.1 JW Medical Systems Details
    • 2.12.2 JW Medical Systems Major Business
    • 2.12.3 JW Medical Systems Sirolimus Coated Stent Product and Services
    • 2.12.4 JW Medical Systems Sirolimus Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 JW Medical Systems Recent Developments/Updates
  • 2.13 SINOMED
    • 2.13.1 SINOMED Details
    • 2.13.2 SINOMED Major Business
    • 2.13.3 SINOMED Sirolimus Coated Stent Product and Services
    • 2.13.4 SINOMED Sirolimus Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 SINOMED Recent Developments/Updates
  • 2.14 Kinhely Bio-Tech
    • 2.14.1 Kinhely Bio-Tech Details
    • 2.14.2 Kinhely Bio-Tech Major Business
    • 2.14.3 Kinhely Bio-Tech Sirolimus Coated Stent Product and Services
    • 2.14.4 Kinhely Bio-Tech Sirolimus Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Kinhely Bio-Tech Recent Developments/Updates
  • 2.15 Shandong Huaan Biotechnology
    • 2.15.1 Shandong Huaan Biotechnology Details
    • 2.15.2 Shandong Huaan Biotechnology Major Business
    • 2.15.3 Shandong Huaan Biotechnology Sirolimus Coated Stent Product and Services
    • 2.15.4 Shandong Huaan Biotechnology Sirolimus Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Shandong Huaan Biotechnology Recent Developments/Updates
  • 2.16 Blue Sail Medical
    • 2.16.1 Blue Sail Medical Details
    • 2.16.2 Blue Sail Medical Major Business
    • 2.16.3 Blue Sail Medical Sirolimus Coated Stent Product and Services
    • 2.16.4 Blue Sail Medical Sirolimus Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Blue Sail Medical Recent Developments/Updates
  • 2.17 Shanghai Bio-heart Biological Technology
    • 2.17.1 Shanghai Bio-heart Biological Technology Details
    • 2.17.2 Shanghai Bio-heart Biological Technology Major Business
    • 2.17.3 Shanghai Bio-heart Biological Technology Sirolimus Coated Stent Product and Services
    • 2.17.4 Shanghai Bio-heart Biological Technology Sirolimus Coated Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Shanghai Bio-heart Biological Technology Recent Developments/Updates

3 Competitive Environment: Sirolimus Coated Stent by Manufacturer

  • 3.1 Global Sirolimus Coated Stent Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Sirolimus Coated Stent Revenue by Manufacturer (2020-2025)
  • 3.3 Global Sirolimus Coated Stent Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Sirolimus Coated Stent by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Sirolimus Coated Stent Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Sirolimus Coated Stent Manufacturer Market Share in 2024
  • 3.5 Sirolimus Coated Stent Market: Overall Company Footprint Analysis
    • 3.5.1 Sirolimus Coated Stent Market: Region Footprint
    • 3.5.2 Sirolimus Coated Stent Market: Company Product Type Footprint
    • 3.5.3 Sirolimus Coated Stent Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Sirolimus Coated Stent Market Size by Region
    • 4.1.1 Global Sirolimus Coated Stent Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Sirolimus Coated Stent Consumption Value by Region (2020-2031)
    • 4.1.3 Global Sirolimus Coated Stent Average Price by Region (2020-2031)
  • 4.2 North America Sirolimus Coated Stent Consumption Value (2020-2031)
  • 4.3 Europe Sirolimus Coated Stent Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Sirolimus Coated Stent Consumption Value (2020-2031)
  • 4.5 South America Sirolimus Coated Stent Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Sirolimus Coated Stent Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Sirolimus Coated Stent Sales Quantity by Type (2020-2031)
  • 5.2 Global Sirolimus Coated Stent Consumption Value by Type (2020-2031)
  • 5.3 Global Sirolimus Coated Stent Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Sirolimus Coated Stent Sales Quantity by Application (2020-2031)
  • 6.2 Global Sirolimus Coated Stent Consumption Value by Application (2020-2031)
  • 6.3 Global Sirolimus Coated Stent Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Sirolimus Coated Stent Sales Quantity by Type (2020-2031)
  • 7.2 North America Sirolimus Coated Stent Sales Quantity by Application (2020-2031)
  • 7.3 North America Sirolimus Coated Stent Market Size by Country
    • 7.3.1 North America Sirolimus Coated Stent Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Sirolimus Coated Stent Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Sirolimus Coated Stent Sales Quantity by Type (2020-2031)
  • 8.2 Europe Sirolimus Coated Stent Sales Quantity by Application (2020-2031)
  • 8.3 Europe Sirolimus Coated Stent Market Size by Country
    • 8.3.1 Europe Sirolimus Coated Stent Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Sirolimus Coated Stent Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Sirolimus Coated Stent Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Sirolimus Coated Stent Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Sirolimus Coated Stent Market Size by Region
    • 9.3.1 Asia-Pacific Sirolimus Coated Stent Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Sirolimus Coated Stent Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Sirolimus Coated Stent Sales Quantity by Type (2020-2031)
  • 10.2 South America Sirolimus Coated Stent Sales Quantity by Application (2020-2031)
  • 10.3 South America Sirolimus Coated Stent Market Size by Country
    • 10.3.1 South America Sirolimus Coated Stent Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Sirolimus Coated Stent Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Sirolimus Coated Stent Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Sirolimus Coated Stent Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Sirolimus Coated Stent Market Size by Country
    • 11.3.1 Middle East & Africa Sirolimus Coated Stent Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Sirolimus Coated Stent Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Sirolimus Coated Stent Market Drivers
  • 12.2 Sirolimus Coated Stent Market Restraints
  • 12.3 Sirolimus Coated Stent Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Sirolimus Coated Stent and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Sirolimus Coated Stent
  • 13.3 Sirolimus Coated Stent Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Sirolimus Coated Stent Typical Distributors
  • 14.3 Sirolimus Coated Stent Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Sirolimus Coated Stent market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Sirolimus coated stent is a medical device used for coronary intervention treatment. The drug coating of the stent contains sirolimus (also known as rapamycin), which is an immunosuppressive drug. The drug will be released onto the vascular wall around the stent, thereby inhibiting intimal hyperplasia and reducing the risk of vascular restenosis. Sirolimus drug coated stents work in two ways: metal stents provide mechanical support to maintain vascular patency; Drug coating releases sirolimus, inhibits vascular intimal hyperplasia, and reduces the possibility of vascular restenosis.
    This report is a detailed and comprehensive analysis for global Sirolimus Coated Stent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Sirolimus Coated Stent market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Sirolimus Coated Stent market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Sirolimus Coated Stent market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Sirolimus Coated Stent market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Sirolimus Coated Stent
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Sirolimus Coated Stent market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include QualiMe, Cardionovum, MicroPort, B. Braun, P+F Products + Features GmbH, Terumo, Biotronik, USM Healthcare, Concept Medical Inc, MicroPort Scientific Corporation, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Sirolimus Coated Stent market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Cobalt Chromium Alloy Material
    Stainless Steel Material
    Others
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    QualiMe
    Cardionovum
    MicroPort
    B. Braun
    P+F Products + Features GmbH
    Terumo
    Biotronik
    USM Healthcare
    Concept Medical Inc
    MicroPort Scientific Corporation
    Lepu Medical Technology
    JW Medical Systems
    SINOMED
    Kinhely Bio-Tech
    Shandong Huaan Biotechnology
    Blue Sail Medical
    Shanghai Bio-heart Biological Technology
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Sirolimus Coated Stent product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Sirolimus Coated Stent, with price, sales quantity, revenue, and global market share of Sirolimus Coated Stent from 2020 to 2025.
    Chapter 3, the Sirolimus Coated Stent competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Sirolimus Coated Stent breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Sirolimus Coated Stent market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Sirolimus Coated Stent.
    Chapter 14 and 15, to describe Sirolimus Coated Stent sales channel, distributors, customers, research findings and conclusion.

    Buy now